Terms: = Liver cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
64 results:
1. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data.
Qu Y; Gong X; Zhao Z; Zhang Z; Zhang Q; Huang Y; Xie Q; Liu Y; Wei J; Du H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255993
[TBL] [Abstract] [Full Text] [Related]
3. Exosomal miR-99b-5p Secreted from Mesenchymal Stem Cells Can Retard the Progression of Colorectal cancer by Targeting fgfr3.
Ning S; Chen Y; Li S; Liu M; Liu H; Ye M; Wang C; Pan J; Wei W; Li J; Zhang L
Stem Cell Rev Rep; 2023 Nov; 19(8):2901-2917. PubMed ID: 37653181
[TBL] [Abstract] [Full Text] [Related]
4. Risk Factors for Lenvatinib-Induced High-Grade Hypothyroidism in Patients with Hepatocellular Carcinoma: A Retrospective Study.
Uekusa S; Nemoto M; Hanai Y; Nakashin M; Miyagawa A; Yanagino S; Arita Y; Matsumoto T; Nishizawa K; Nagai H; Higai K; Matsuo K
Pharmacology; 2023; 108(5):460-468. PubMed ID: 37591220
[TBL] [Abstract] [Full Text] [Related]
5. Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression.
Yu M; Huang L; Zhang S; Jiang L; Jin Y; Gu M; Liao J; Zhang J
Front Cell Infect Microbiol; 2023; 13():1082390. PubMed ID: 36761898
[TBL] [Abstract] [Full Text] [Related]
6. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.
Tao Z; Cui Y; Xu X; Han T
Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2208844119. PubMed ID: 36179047
[TBL] [Abstract] [Full Text] [Related]
7. Surveillance Patterns for Hepatocellular Carcinoma among Screening-Eligible Patients in the Medicare Population.
Papageorge MV; de Geus SWL; Woods AP; Ng SC; Lee S; McAneny D; Tseng JF; Kenzik KM; Sachs TE
Ann Surg Oncol; 2022 Dec; 29(13):8424-8431. PubMed ID: 36057903
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of fgfr3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma.
Chen YH; Yang SH; Liu LX; Hu S; Wang XJ; Liao ZJ; Huan YF; He K; Zhang XW
Dig Liver Dis; 2023 Mar; 55(3):400-406. PubMed ID: 35999136
[TBL] [Abstract] [Full Text] [Related]
9. Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.
Tomczak A; Springfeld C; Dill MT; Chang DH; Kazdal D; Wagner U; Mehrabi A; Brockschmidt A; Luedde T; Naumann P; Stenzinger A; Schirmacher P; Longerich T
Br J Cancer; 2022 Nov; 127(9):1701-1708. PubMed ID: 35986087
[TBL] [Abstract] [Full Text] [Related]
10. Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis.
Kamp EJ; Dinjens WN; Doukas M; van Marion R; Verheij J; Ponsioen CY; Bruno MJ; Groot Koerkamp B; Trivedi PJ; Peppelenbosch MP; de Vries AC
J Pathol; 2022 Nov; 258(3):227-235. PubMed ID: 35897137
[TBL] [Abstract] [Full Text] [Related]
11. Molecular docking and dynamic simulations of
Sangeetha R; Arockia Jeya Yasmi Prabha E; Lakshmi A; Sangavi P; Langeswaran K
J Biomol Struct Dyn; 2022; 40(24):13997-14012. PubMed ID: 34738880
[TBL] [Abstract] [Full Text] [Related]
12. Can abdominal CT features predict autonomous cortisol secretion in patients with adrenal nodules?
Corwin MT; Lan C; Wilson M; Loehfelm TW; Campbell MJ
Abdom Radiol (NY); 2021 Sep; 46(9):4338-4344. PubMed ID: 33963418
[TBL] [Abstract] [Full Text] [Related]
13. Complications After Complex Gastrointestinal cancer Surgery: Benefits and Costs Associated with Inter-hospital Transfer Among Medicare Beneficiaries.
Pathak P; Dalmacy D; Tsilimigras DI; Hyer JM; Diaz A; Pawlik TM
J Gastrointest Surg; 2021 Jun; 25(6):1370-1379. PubMed ID: 33914214
[TBL] [Abstract] [Full Text] [Related]
14. Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma.
Bansal P; Dwivedi DK; Hatwal D; Sharma P; Gupta V; Goyal S; Maithani M
Anticancer Agents Med Chem; 2021; 21(18):2478-2486. PubMed ID: 33475078
[TBL] [Abstract] [Full Text] [Related]
15. fgfr3
Jin Z; Feng H; Liang J; Jing X; Zhao Q; Zhan L; Shen B; Cheng X; Su L; Qiu W
Cell Death Dis; 2020 Oct; 11(10):903. PubMed ID: 33097695
[TBL] [Abstract] [Full Text] [Related]
16. When does a Pringle Maneuver cause harm?
Fagenson AM; Gleeson EM; Nabi F; Lau KN; Pitt HA
HPB (Oxford); 2021 Apr; 23(4):587-594. PubMed ID: 32933844
[TBL] [Abstract] [Full Text] [Related]
17. Interaction of FGF9 with fgfr3-IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma.
Paur J; Valler M; Sienel R; Taxauer K; Holzmann K; Marian B; Unterberger A; Mohr T; Berger W; Gvozdenovich A; Schimming J; Grusch M; Grasl-Kraupp B
Liver Int; 2020 Sep; 40(9):2279-2290. PubMed ID: 32378800
[TBL] [Abstract] [Full Text] [Related]
18. A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
Yamano T; Kubo S; Tomita N
Cancer Med; 2020 May; 9(10):3337-3343. PubMed ID: 32168428
[TBL] [Abstract] [Full Text] [Related]
19. Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study.
Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X
J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699
[TBL] [Abstract] [Full Text] [Related]
20. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.
Zhang G; Tang X; Liang L; Zhang W; Li D; Li X; Zhao D; Zheng Y; Chen Y; Hao B; Wang K; Tang N; Ding K
Oncogene; 2020 Apr; 39(16):3229-3244. PubMed ID: 32071398
[TBL] [Abstract] [Full Text] [Related]
[Next]
